Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity

Abstract

Our findings identified the endogenous rolling-translated protein and provided strong clinical evidence that targeting rtEGFR could improve the efficiency of EGFR-targeting therapies in GBM.